ArticleOncology letters2018

Retrospective study of regorafenib and trifluridine/tipiracil efficacy as a third-line or later chemotherapy regimen for refractory metastatic colorectal cancer.

Akira Tanaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.